FNDC5 and polycystic ovary syndrome: These results indicate that r-irisin treatment may have both beneficial and negative effects on the gut microbiota, and the beneficial effects of the drug on improving PCOS phenotypes may be, at least in part, due to changes in the gut microbiota.